Should noninvasive ventilation be considered a high-risk procedure during an epidemic?
McCracken
John
J
Department of Respiratory Therapy, Petersborough Regional Health Centre, Peterborough, Ontario. john.mccracken@sympatico.ca
D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D017053:Infection Control / Q000592:standards / Q000639:trends; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control / Q000706:statistics & numerical data; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D007362:Intensive Care Units; D011175:Positive-Pressure Respiration / Q000009:adverse effects* / Q000379:methods; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology / Q000628:therapy